Jacobs Levy Equity Management
ICPT

Jacobs Levy Equity Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Jacobs Levy Equity Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-861,801
Closed -$9.53M – 1096
2023
Q2 		$9.53M Sell
861,801
-61,568
-7% -$858K 0.05% 283
2023
Q1 		$12.4M Buy
923,369
+262
+0% +$4.53K 0.08% 253
2022
Q4 		$11.4M Buy
923,107
+142,162
+18% +$2.01M 0.08% 263
2022
Q3 		$10.9M Buy
780,945
+135,254
+21% +$2.18M 0.09% 246
2022
Q2 		$8.92M Buy
645,691
+53,387
+9% +$855K 0.07% 300
2022
Q1 		$9.64M Buy
592,304
+3,382
+0.6% +$53K 0.06% 299
2021
Q4 		$9.59M Buy
588,922
+54,746
+10% +$923K 0.06% 309
2021
Q3 		$7.93M Sell
534,176
-79,712
-13% -$1.28M 0.05% 349
2021
Q2 		$12.3M Buy
613,888
+81,786
+15% +$1.62M 0.08% 255
2021
Q1 		$12.3M Buy
532,102
+52,378
+11% +$1.46M 0.09% 248
2020
Q4 		$11.8M Buy
479,724
+132,478
+38% +$4.39M 0.1% 226
2020
Q3 		$14.4M Buy
347,246
+297,789
+602% +$13.7M 0.15% 156
2020
Q2 		$2.37M Buy
49,457
+5,455
+12% +$421K 0.03% 495
2020
Q1 		$2.77M Sell
44,002
-340
-0.8% -$30.6K 0.04% 416
2019
Q4 		$5.5M Buy
44,342
+4,050
+10% +$363K 0.05% 351
2019
Q3 		$2.67M Buy
+40,292
New +$2.71M 0.03% 454
2016
Q3 		– Sell
-8,120
Closed -$1.16M – 1159
2016
Q2 		$1.16M Sell
8,120
-4,920
-38% -$717K 0.02% 545
2016
Q1 		$1.68M Buy
+13,040
New +$1.54M 0.04% 450

Other funds holding ICPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jacobs Levy Equity Management's ICPT Position: Q3 2023 in Review

Jacobs Levy Equity Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 861,801 shares — an estimated $9.53M sold.

Jacobs Levy Equity Management first reported a position in ICPT in Q1 2016 and held it in 18 quarters. The position peaked at $14.4M in Q3 2020. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • Jacobs Levy Equity Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 861,801 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $9.53M.
  • Jacobs Levy Equity Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2016 and held it in 18 quarters.
  • Jacobs Levy Equity Management's Intercept Pharmaceuticals, Inc. position peaked at $14.4M in Q3 2020.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2023, filed 17 Nov 2023.